CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company
Neumora Therapeutics, Inc.
Sign in to watch- Ticker
- NMRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844367680
- Phone
- (857) 760-0900
- Business address
- 260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $481,506
- in 2 filings
Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-17 | Fust Matthew K Director | Sale 10b5-1 | −7,739 | $17.01 | $132K | 20,100 |
| 2024-10-17 | Fust Matthew K Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,783 | 0 | ||
| 2024-10-17 | Fust Matthew K Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,800 | 6,205 | ||
| 2024-10-17 | Fust Matthew K Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,156 | 93,430 | ||
| 2024-10-10 | Lenz Robert A. Head of R&D | Sale 10b5-1 | −8,260 | $15.09 | $125K | 314,706 |
| 2024-10-09 | Lenz Robert A. Head of R&D | Sale 10b5-1 | −5,563 | $15.01 | $84K | 322,966 |
| 2024-09-18 | Lenz Robert A. Head of R&D | Sale 10b5-1 | −10,676 | $12.09 | $129K | 328,529 |
| 2024-09-17 | Lenz Robert A. Head of R&D | Sale 10b5-1 | −30,788 | $11.81 | $364K | 339,205 |
| 2024-09-12 | Lenz Robert A. Head of R&D | Sale 10b5-1 | −32,948 | $11.43 | $377K | 369,993 |
| 2024-09-12 | Aurora Daljit Singh Chief Strategy Officer | Gift · Stock Option (Right to Buy) | −137,538 | 40,890 | ||
| 2024-09-12 | Aurora Daljit Singh Chief Strategy Officer | Gift · Stock Option (Right to Buy) | +137,538 | 137,538 | ||
| 2024-09-12 | Aurora Daljit Singh Chief Strategy Officer | Gift · Stock Option (Right to Buy) | −136,210 | 207,901 | ||
| 2024-09-12 | Aurora Daljit Singh Chief Strategy Officer | Gift · Stock Option (Right to Buy) | +136,210 | 136,210 | ||
| 2024-09-12 | Aurora Daljit Singh Chief Strategy Officer | Gift · Stock Option (Right to Buy) | −29,737 | 72,221 | ||
| 2024-09-12 | Aurora Daljit Singh Chief Strategy Officer | Gift · Stock Option (Right to Buy) | +29,737 | 29,737 | ||
| 2024-08-27 | Pinto Joshua Chief Financial Officer | Sale 10b5-1 | −15,693 | $11.39 | $179K | 138,965 |
| 2024-08-26 | Pinto Joshua Chief Financial Officer | Sale 10b5-1 | −31,642 | $11.78 | $373K | 154,658 |
| 2024-08-23 | Pinto Joshua Chief Financial Officer | Sale 10b5-1 | −24,169 | $11.59 | $280K | 186,300 |
| 2024-08-22 | Pinto Joshua Chief Financial Officer | Sale 10b5-1 | −28,496 | $11.63 | $331K | 210,469 |
| 2024-06-13 | Ho Maykin Director | Grant or award | +20,100 | 20,100 |
Page 13 of 20 · 384 trades